BOSTON SCIENTIFIC CORP
BSXNYSE🏆 #237 by market capEarnings Oct 28 · PreUS Equity
$43.25▼ $0.85 (−1.96%)
LiveTrack BSX
Get earnings, price moves & breaking news on Telegram
24h▼ 2.0%
7d▼ 3.8%
14d▼ 1.4%
30d▼ 7.7%
ytd▼ 54.6%
1y▼ 55.4%
🏦Market Cap
$64.28B
Mid Cap
📈Revenue Growth (YoY)
+19.9%
Healthy
📊Gross Margin
71.2%
High
💵FCF Margin
17.3%
Healthy
⚖️P/S Ratio
3.1x
Fair
Otter Score
68
Fair
BOSTON SCIENTIFIC CORP
BSXAnalyst Ratings
Price
$43.25
Total
44
Raised
5
Lowered
5
Avg PT
$65.20
H / L
$100 / $48
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Wells Fargo | Reiterated | Equal Weight | 2026-09-24 | $48.00 | +11.00% |
Oppenheimer | Reiterated | Outperform | 2026-09-21 | $65.00 | +50.30% |
Citigroup | Downgraded | Buy → Neutral | 2026-09-17 | — | — |
BTIG | Reiterated | Buy | 2026-09-09 | $56.00 | +29.50% |
TD Cowen | Reiterated | Buy | 2026-08-25 | — | — |
Argus Research | Downgraded | Buy → Hold | 2026-07-31 | $130.00 | +200.60% |
UBS | Reiterated | Buy | 2026-07-30 | $67.00 | +54.90% |
Evercore ISI Group | Reiterated | Outperform | 2026-07-30 | — | — |
Truist Securities | Reiterated | Buy | 2026-07-30 | — | — |
Canaccord Genuity | Reiterated | Buy | 2026-07-30 | $66.00 | +52.60% |
RBC Capital | Reiterated | Outperform | 2026-07-30 | $70.00 | +61.90% |
Mizuho | Reiterated | Outperform | 2026-07-15 | — | — |
Needham | Reiterated | Buy | 2026-07-08 | $57.00 | +31.80% |
Stifel | Reiterated | Buy | 2026-06-25 | — | — |
Jefferies | Reiterated | Buy | 2026-06-24 | $100.00 | +131.20% |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2026-05-29 | — | — |
Leerink Partners | Reiterated | Outperform | 2026-05-28 | $60.00 | +38.70% |
Barclays | Reiterated | Overweight | 2026-05-28 | $89.00 | +105.80% |
Baird | Reiterated | Outperform | 2026-05-19 | — | — |
B of A Securities | Reiterated | Buy | 2026-05-18 | — | — |
Goldman Sachs | Reiterated | Buy | 2026-04-23 | $71.00 | +64.20% |
Raymond James | Downgraded | Strong Buy → Outperform | 2026-03-30 | $57.00 | +31.80% |
JP Morgan | Reiterated | Overweight | 2026-02-05 | — | — |
Morgan Stanley | Reiterated | Overweight | 2026-02-05 | $130.00 | +200.60% |
Piper Sandler | Reiterated | Overweight | 2025-02-03 | $65.00 | +50.30% |
Bernstein | Reiterated | Outperform | 2024-10-24 | $112.00 | +159.00% |
Deutsche Bank | Reiterated | Hold | 2024-07-25 | $60.00 | +38.70% |
SVB Leerink | Reiterated | Market Perform | 2022-04-28 | — | — |
Credit Suisse | Reiterated | Outperform | 2021-07-28 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-04-23 | — | — |
Stephens & Co. | Reiterated | Overweight | 2020-03-26 | — | — |
CFRA | Upgraded | Buy → Strong Buy | 2020-03-09 | — | — |
Cowen & Co. | Reiterated | Outperform | 2019-12-30 | — | — |
Argus | Reiterated | Buy | 2018-10-26 | — | — |
Leerink Swann | Reiterated | Outperform | 2018-04-26 | — | — |
Bank of America | Reiterated | Buy | 2018-04-05 | — | — |
BTIG Research | Upgraded | Neutral → Buy | 2017-11-30 | — | — |
BMO Capital | Reiterated | Outperform | 2017-10-27 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2015-07-24 | $60.00 | +38.70% |
JMP Securities | Reiterated | Market Outperform | 2015-02-04 | — | — |
Benchmark | Upgraded | Hold → Buy | 2014-10-22 | — | — |
PiperJaffray | Upgraded | Neutral → Overweight | 2014-01-21 | — | — |
CL King | Downgraded | Strong Buy → Neutral | 2013-09-10 | $90.00 | +108.10% |
S&P Capital IQ | Upgraded | Hold → Buy | 2013-06-28 | — | — |
Institution
Wells Fargo
Reiterated · Equal Weight · 2026-09-24
$48.00
+11.00%
Oppenheimer
Reiterated · Outperform · 2026-09-21
$65.00
+50.30%
Citigroup
Downgraded · Buy → Neutral · 2026-09-17
—
—
BTIG
Reiterated · Buy · 2026-09-09
$56.00
+29.50%
TD Cowen
Reiterated · Buy · 2026-08-25
—
—
Argus Research
Downgraded · Buy → Hold · 2026-07-31
$130.00
+200.60%
UBS
Reiterated · Buy · 2026-07-30
$67.00
+54.90%
Evercore ISI Group
Reiterated · Outperform · 2026-07-30
—
—
Truist Securities
Reiterated · Buy · 2026-07-30
—
—
Canaccord Genuity
Reiterated · Buy · 2026-07-30
$66.00
+52.60%
RBC Capital
Reiterated · Outperform · 2026-07-30
$70.00
+61.90%
Mizuho
Reiterated · Outperform · 2026-07-15
—
—
Needham
Reiterated · Buy · 2026-07-08
$57.00
+31.80%
Stifel
Reiterated · Buy · 2026-06-25
—
—
Jefferies
Reiterated · Buy · 2026-06-24
$100.00
+131.20%
Wolfe Research
Downgraded · Outperform → Peer Perform · 2026-05-29
—
—
Leerink Partners
Reiterated · Outperform · 2026-05-28
$60.00
+38.70%
Barclays
Reiterated · Overweight · 2026-05-28
$89.00
+105.80%
Baird
Reiterated · Outperform · 2026-05-19
—
—
B of A Securities
Reiterated · Buy · 2026-05-18
—
—
Goldman Sachs
Reiterated · Buy · 2026-04-23
$71.00
+64.20%
Raymond James
Downgraded · Strong Buy → Outperform · 2026-03-30
$57.00
+31.80%
JP Morgan
Reiterated · Overweight · 2026-02-05
—
—
Morgan Stanley
Reiterated · Overweight · 2026-02-05
$130.00
+200.60%
Piper Sandler
Reiterated · Overweight · 2025-02-03
$65.00
+50.30%
Bernstein
Reiterated · Outperform · 2024-10-24
$112.00
+159.00%
Deutsche Bank
Reiterated · Hold · 2024-07-25
$60.00
+38.70%
SVB Leerink
Reiterated · Market Perform · 2022-04-28
—
—
Credit Suisse
Reiterated · Outperform · 2021-07-28
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-04-23
—
—
Stephens & Co.
Reiterated · Overweight · 2020-03-26
—
—
CFRA
Upgraded · Buy → Strong Buy · 2020-03-09
—
—
Cowen & Co.
Reiterated · Outperform · 2019-12-30
—
—
Argus
Reiterated · Buy · 2018-10-26
—
—
Leerink Swann
Reiterated · Outperform · 2018-04-26
—
—
Bank of America
Reiterated · Buy · 2018-04-05
—
—
BTIG Research
Upgraded · Neutral → Buy · 2017-11-30
—
—
BMO Capital
Reiterated · Outperform · 2017-10-27
—
—
Stifel Nicolaus
Reiterated · Buy · 2015-07-24
$60.00
+38.70%
JMP Securities
Reiterated · Market Outperform · 2015-02-04
—
—
Benchmark
Upgraded · Hold → Buy · 2014-10-22
—
—
PiperJaffray
Upgraded · Neutral → Overweight · 2014-01-21
—
—
CL King
Downgraded · Strong Buy → Neutral · 2013-09-10
$90.00
+108.10%
S&P Capital IQ
Upgraded · Hold → Buy · 2013-06-28
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space